Iovance Biotherapeutics IOVA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.73 | 699 | -10.27 | -72 | -7.91 | 913 |
| 2025Q3 | 2.17 | 702 | -13.03 | -91 | -10.07 | 905 |
| 2025Q2 | 1.72 | 698 | -15.23 | -112 | -11.92 | 907 |
| 2025Q1 | 3.33 | 768 | -15.72 | -116 | -12.38 | 967 |
| 2024Q4 | 7.40 | 710 | -10.59 | -79 | -8.26 | 910 |
| 2024Q3 | 9.39 | 773 | -10.84 | -84 | -8.54 | 991 |
| 2024Q2 | 8.02 | 769 | -13.41 | -97 | -10.59 | 964 |
| 2024Q1 | 14.82 | 680 | -17.87 | -113 | -13.69 | 870 |
| 2023Q4 | 8.13 | 585 | -18.49 | -116 | -14.26 | 780 |
| 2023Q3 | 4.55 | 674 | -18.16 | -114 | -14.14 | 852 |
| 2023Q2 | 7.04 | 579 | -17.11 | -107 | -13.47 | 757 |
| 2023Q1 | 6.11 | 667 | -18.41 | -107 | -14.42 | 825 |
| 2022Q4 | 6.39 | 500 | -23.58 | -105 | -17.41 | 664 |
| 2022Q3 | 9.58 | 394 | -23.00 | -100 | -17.22 | 546 |
| 2022Q2 | 11.04 | 473 | -19.39 | -99 | -15.14 | 611 |
| 2022Q1 | 16.65 | 552 | -15.61 | -92 | -12.39 | 701 |
| 2021Q4 | 19.09 | 622 | -15.05 | -99 | -12.37 | 777 |
| 2021Q3 | 24.66 | 698 | -11.94 | -86 | -10.24 | 829 |
| 2021Q2 | 26.02 | 744 | -11.69 | -81 | -10.15 | 853 |
| 2021Q1 | 31.66 | 647 | -11.57 | -75 | -9.93 | 751 |